CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED) - USD ($) $ in Millions	3 Months Ended			12 Months Ended
	Mar. 31, 2023	Mar. 31, 2022		Dec. 31, 2022		Dec. 31, 2021
Cash Flows from Operating Activities
Net income	$ 417	$ 825	[1]	$ 3,149		$ 3,417
Adjustments to reconcile net income to net cash provided by (used in) operating activities:
Depreciation, amortization and accretion, net	(35)	(12)	[2]
Deferred income tax expense (benefit)	(48)	171	[2]
Share-based compensation	46	44	[2]
Net realized investment gains	(7)	(18)	[2]
Net trading (gains) losses	(9)	0	[2]
Loss from equity method investments	11	12	[2]
Impairments and provision for loan and credit losses	5	0	[2]
Net (gains) losses of consolidated investment entities	6	3	[2]
Changes in operating assets and liabilities:
Restricted and segregated investments	(123)	(124)	[2]
Deferred acquisition costs	23	15	[2]
Policyholder account balances, future policy benefits and claims, and market risk benefits, net	1,073	(236)	[2]
Derivatives, net of collateral	(242)	(4)	[2]
Receivables	256	(96)	[2]
Brokerage deposits	(314)	120	[2]
Accounts payable and accrued expenses	(219)	(461)	[2]
Current income tax, net	80	(27)	[2]
Deferred taxes, net	7	2	[2]
Other operating assets and liabilities of consolidated investment entities, net	(6)	8	[2]
Other, net	135	187	[2]
Net cash provided by (used in) operating activities	1,056	409	[2]
Available-for-Sale securities:
Proceeds from sales	313	0	[2]
Maturities, sinking fund payments and calls	1,464	2,209	[2]
Purchases	(5,098)	(3,972)	[2]
Proceeds from sales, maturities and repayments of mortgage loans	41	32	[2]
Funding of mortgage loans	(52)	(51)	[2]
Proceeds from sales, maturities and collections of other investments	31	15	[2]
Purchase of other investments	(24)	(5)	[2]
Purchase of investments by consolidated investment entities	(122)	(190)	[2]
Proceeds from sales, maturities and repayments of investments by consolidated investment entities	182	183	[2]
Purchase of land, buildings, equipment and software	(41)	(44)	[2]
Cash paid for written options with deferred premiums	(59)	0	[2]
Cash received from written options with deferred premiums	24	12	[2]
Cash paid for deposit receivables	(10)	(12)	[2]
Cash received for deposit receivables	210	134	[2]
Other, net	(5)	24	[2]
Net cash provided by (used in) investing activities	(3,146)	(1,665)	[2]
Investment certificates:
Proceeds from additions	3,590	733	[2]
Maturities, withdrawals and cash surrenders	(1,822)	(835)	[2]
Policyholder account balances:
Deposits and other additions	339	285	[2]
Net transfers from (to) separate accounts	(19)	(57)	[2]
Surrenders and other benefits	(569)	(328)	[2]
Change in banking deposits, net	1,702	1,802	[2]
Cash paid for purchased options with deferred premiums	(24)	(71)	[2]
Cash received from purchased options with deferred premiums	8	168	[2]
Issuance of long-term debt, net of issuance costs	741	0	[2]
Repayments of long-term debt	(2)	(502)	[2]
Dividends paid to shareholders	(134)	(129)	[2]
Repurchase of common shares	(617)	(541)	[2]
Repayments of debt by consolidated investment entities	(31)	(1)	[2]
Other, net	0	(6)	[2]
Net cash provided by (used in) financing activities	3,162	518	[2]
Effect of exchange rate changes on cash	11	(20)	[2]
Net increase (decrease) in cash and cash equivalents, including amounts restricted	1,083	(758)	[2]
Cash and cash equivalents, including amounts restricted, at beginning of period	8,755	9,569	[2]	9,569	[2]
Cash and cash equivalents, including amounts restricted, at end of period	9,838	8,811	[2]	8,755		9,569	[2]
Supplemental Disclosures:
Income taxes paid, net	33	34	[2]
Leased assets obtained in exchange for operating lease liabilities	7	13	[2]
Reconciliation of cash and cash equivalents, including amounts restricted:
Restricted and segregated cash, cash equivalents and investments	1,984			2,229	[3]
Less: Restricted and segregated investments	(694)			(571)
Total cash and cash equivalents including amounts restricted	9,838	8,811	[2]	8,755		$ 9,569	[2]
Ameriprise Financial
Supplemental Disclosures:
Interest paid	112	27	[2]
Reconciliation of cash and cash equivalents, including amounts restricted:
Cash and cash equivalents	8,386			6,964	[3]
Consolidated investment entities
Supplemental Disclosures:
Interest paid	44	$ 13	[2]
Reconciliation of cash and cash equivalents, including amounts restricted:
Cash and cash equivalents	$ 162			$ 133	[3]

[1] Certain prior period amounts have been restated. See Note 3 for more information.

[2] Certain prior period amounts have been restated. See Note 3 for more information.

[3] Certain prior period amounts have been restated. See Note 3 for more information.